Skip to content

Increased fat consumption observed in people with HIV with high cholesterol

HIV/HBV coinfected patients should not take entecavir unless on anti-HIV treatment due to resistance risk

Frequency and seriousness of lactic acidosis mean that d4T should not be used in first-line therapy, say Ugandan researchers

Viral load during primary infection influences viral load for years after

Patients with renal impairment often receive wrong NRTI dose, particular risk with combination pills

First fixed dose combination for children approved for PEPFAR use

Use CD4 cell count, not CD4 cell percentage to guide treatment decisions in all patients with HIV, even those with cirrhosis

IAS: Maraviroc produces best results when combined with another active drug

IAS: Boosted atazanavir shows edge over unboosted in treatment-naive after 96 weeks